drugset / Trial / NCT00003147

Gene Therapy in Treating Patients With Cancer of The Liver

NCT00003147

Phase 1 Terminated 30 enrolled National Cancer Institute (NCI)
NaSingle-groupOpen-labelTreatment

Summary

Phase I trial to study the effectiveness of gene therapy with the p53 gene in treating patients who have cancer of the liver that cannot be surgically removed. Inserting the p53 gene into a person's tumor may improve the body's ability to fight liver cancer.

Timeline

Start
1998-02
Primary completion
2003-06
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject CONTUSUGENE LADENOVEC Unknown Other

Indications